PeopleBio Delays Reverse Stock Split Effective Date to Nov. 6, 2026
Bitget2026/10/21 06:25- PeopleBio postponed its 1-for-2 reverse stock split’s effective date to Nov. 6, 2026, from Aug. 5, 2026, in a corrected filing.
- The schedule change follows consultations with relevant institutions over listing common shares converted from convertible preferred shares.
- Conversion of 590,022 convertible preferred shares into 773,420 common shares raises the revised post-split common share count to 12,547,040 from 12,160,330.
- Trading is scheduled to remain suspended through Nov. 19, 2026, with the new shares scheduled to list Nov. 20, 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Trump Media & Technology Group plunges over 24%, hitting a new low since listing.
South Korea’s current account surplus in September exceeded 60 billions USD for the first time, with semiconductor exports becoming the main driver
Driven by booming semiconductor exports, South Korea's current account surplus in September surged to a record high.
CoreWeave (CRWV.US) bonds hit a new low as changes in Texas data center policies impact AI cloud trading
CoreWeave (CRWV.US) bonds fell sharply on Wednesday, with some dropping to new lows.
AstraZeneca (AZN.US) reportedly receives a $10 billion acquisition offer! Shares of obesity drug developer Rhythm (RYTM.US) soar in response
According to three people familiar with the matter, AstraZeneca previously proposed to acquire obesity drug developer Rhythm Pharmaceuticals for approximately 10 billion dollars.
Crypto prices
More
